AbCellera Biologics Inc. ABCL Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s net income?
- AbCellera Biologics Inc. (ABCL) reported net income of -$43.17M in Q1 2026.
- How has AbCellera Biologics Inc.'s net income changed year-over-year?
- AbCellera Biologics Inc.'s net income increased by 5.4% year-over-year, from -$45.62M to -$43.17M.
- What is the long-term trend for AbCellera Biologics Inc.'s net income?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s net income has grown at a -1.6% compound annual growth rate (CAGR), from $153.47M to -$146.41M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.